Nguyen Phu Hung, Le Thi Thanh Huong, Nguyen Trung Thanh

Main Article Content

Abstract

According to estimates by the World Health Organization (WHO), in 2018 there were over one million new stomach cancer patients. Vietnam ranks the tenth among the countries with the highest rates of stomach cancer in the world, with the rate of 15.9 cases per 100,000 populations. Research on compounds or drugs that can inhibit cancer cell growth but are less toxic to the body is necessary. In this study, using MTT assays, we have shown that curcumin has ability to inhibit proliferation of stomach cancer cells MKN45. Flow cytometry analysis showed that curcumin increased the percentage of apoptosis cells by 27 - 56% at concentrations of 10 µM - 20 µM and resulted in a typical nuclear morphology of apoptosis. Further, this study showed that curcumin significantly reduced the expression of aldehyde dehydrogenase protein in MKN45 gastric cancer cells. This finding shows that curcumin is a potential therapeutic candidate for gastric cancer cell treatment.

Keywords: curcumin, gastric cancer stem cell, cancer stem cell marker, aldehyde dehydrogenase.

References

P. Rawla, A. Barsouk, Epidemiology of gastric cancer: global trends, risk factors and prevention, Pg 14 (2019) 26-38. https://doi.org/10.5114/pg. 2018.80001.
[2] A. Lichota, K. Gwozdzinski, Anticancer Activity of Natural Compounds from Plant and Marine Environment, Int J Mol Sci 19 (2018). https://doi.org/10.3390/ijms19113533.
[3] A. Giordano, G. Tommonaro, Curcumin and Cancer, Nutrients 11 (2019). https://doi.org/10. 3390/nu11102376.
[4] W. Yim-im, O. Sawatdichaikul, S. Semsri, N. Horata, W. Mokmak, S. Tongsima, et al, Computational analyses of curcuminoid analogs against kinase domain of HER2, BMC Bioinformatics 15 (2014) 261. https://doi.org/10. 1186/1471-2105-15-261.
[5] S. Lev-Ari, A. Starr, A. Vexler, V. Karaush, V. Loew, J. Greif, et al, Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity, Anticancer Res 26 (2006) 4423–30.
[6] C.W. Yang, C.L. Chang, H.C. Lee, C.W. Chi, J.P. Pan, W.C. Yang, Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways, BMC Complement Altern Med (2012) 12 - 22.
[7] K. Wang, H. Fan, Q. Chen, G. Ma, M. Zhu, X. Zhang, et al, Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro, Anticancer Drugs 26 (2015) 15-24. https://doi.org/10.1097/CAD.0000000000000132.
[8] T. Hassanalilou, S. Ghavamzadeh, L. Khalili, Curcumin and Gastric Cancer: a Review on Mechanisms of Action, J Gastrointest Cancer 50 (2019) 185-92. https://doi.org/10.1007/s12029-018-00186-6.
[9] G. Liu, T. Xiang, Q.F. Wu, W.X. Wang, Curcumin suppresses the proliferation of gastric cancer cells by downregulating H19, Oncol Lett 12 (2016) 5156-62. https://doi.org/10.3892/ol. 2016.5354.
[10] R. Zheng, Q. Deng, Y. Liu, P. Zhao, Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway, Med Sci Monit 23 (2017) 163-71. https://doi.org/10.12659/msm. 902711.
[11] G. Muzio, M. Maggiora, E. Paiuzzi, M. Oraldi, R.A. Canuto, Aldehyde dehydrogenases and cell proliferation, Free Radic Biol Med 52 (2012) 735–46. https://doi.org/10.1016/j.freeradbiomed. 2011.11.033.
[12] C. Riccardi, I. Nicoletti, Analysis of apoptosis by propidium iodide staining and flow cytometry, Nat Protoc 1 (2006) 1458–61. https://doi.org/10. 1038/nprot.2006.238.
[13] Y. Fuchs, H. Steller, Programmed cell death in animal development and disease, Cell 147 (2011) 742–58.https://doi.org/10.1016/j.cell.2011. 10.033.
[14] P.H. Nguyen, J. Giraud, C. Staedel, L. Chambonnier, P. Dubus, E. Chevret, et al, All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth, Oncogene 35 (2016) 5619–28. https://doi.org/10.1038/onc.2016.87.
[15] V. Vasiliou, D.C. Thompson, C. Smith, M. Fujita, Y. Chen, Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells, Chem Biol Interact 202 (2013) 2–10. https://doi.org/10.1016/j.cbi.2012.10.026.
[16] P.H. Nguyen, J. Giraud, L. Chambonnier, P. Dubus, L. Wittkop, G. Belleannée, et al, Characterization of Biomarkers of Tumorigenic and Chemoresistant Cancer Stem Cells in Human Gastric Carcinoma, Clin Cancer Res 23 (2017) 1586-97.https://doi.org/10.1158/1078-0432. CCR -15-2157.
[17] J. Ikeda, S. Mamat, T. Tian, Y. Wang, W. Luo, N. Rahadiani, et al, Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells, Lab Invest 92 (2012) 606–14. https://doi.org/10.1038/labinvest.2012.4.